Spdr Sp Pharmaceuticals Etf Profile
| XPH Etf | USD 39.79 0.49 1.25% |
Performance0 of 100
| Odds Of DistressLess than 38
|
SPDR SP is trading at 39.79 as of the 23rd of April 2024. This is a 1.25% increase since the beginning of the trading day. The etf's open price was 39.3. SPDR SP has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for SPDR SP Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of July 2023 and ending today, the 23rd of April 2024. Click here to learn more.
In seeking to track the performance of the SP Pharmaceuticals Select Industry Index , the fund employs a sampling strategy. SP Pharmaceuticals is traded on NYSEARCA Exchange in the United States. More on SPDR SP Pharmaceuticals
Moving together with SPDR Etf
| 0.71 | XLV | Health Care Select | PairCorr |
| 0.72 | VHT | Vanguard Health Care | PairCorr |
| 0.82 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.76 | XBI | SPDR SP Biotech | PairCorr |
| 0.65 | IXJ | iShares Global Healthcare | PairCorr |
| 0.73 | IYH | iShares Healthcare ETF | PairCorr |
SPDR Etf Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. SPDR SP's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding SPDR SP or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Trustee | James Ross |
| Thematic Ideas | (View all Themes) |
| Old Names | [Hanoi Soap JSC, Ssga Spdr Pharmaceuticals] |
| Business Concentration | Sector ETFs, Health Care ETFs, Health, SPDR State Street Global Advisors (View all Sectors) |
| Issuer | SSgA |
| Inception Date | 2006-06-19 |
| Benchmark | S&P Pharmaceuticals Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 189.9 Million |
| Average Trading Valume | 43,775.3 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
| Region | North America |
| Administrator | SSgA Funds Management, Inc. |
| Advisor | SSgA Funds Management, Inc. |
| Custodian | State Street Bank and Trust Company |
| Distributor | State Street Global Advisors Funds Distributors, LLC |
| Portfolio Manager | Michael Feehily, Karl Schneider, Keith Richardson |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 30-Jun |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 42.0 |
| Market Maker | Citadel |
| Total Expense | 0.35 |
| Management Fee | 0.35 |
| Country Name | USA |
| Returns Y T D | (5.57) |
| Name | SPDR SP Pharmaceuticals ETF |
| Currency Code | USD |
| Open Figi | BBG000D73SW9 |
| In Threey Volatility | 16.91 |
| 1y Volatility | 23.16 |
| 200 Day M A | 41.0578 |
| 50 Day M A | 42.7802 |
| Code | XPH |
| Updated At | 23rd of April 2024 |
| Currency Name | US Dollar |
SPDR SP Pharmaceuticals [XPH] is traded in USA and was established 2006-06-19. The fund is classified under Health category within SPDR State Street Global Advisors family. The entity is thematically classified as Sector ETFs. SPDR SP Pharmaceuticals at this time have 206.63 M in net assets. , while the total return for the last 3 years was -5.5%.
Check SPDR SP Probability Of Bankruptcy
Geographic Allocation (%)
Top SPDR SP Pharmaceuticals Etf Constituents
| MNK | Mallinckrodt Plc | Stock | Health Care |
| MRK | Merck Company | Stock | Health Care |
| ZTS | Zoetis Inc | Stock | Health Care |
| VTRS | Viatris | Stock | Health Care |
| SAVA | Cassava Sciences | Stock | Health Care |
| RPRX | Royalty PharmaPlc | Stock | Health Care |
| RETA | Reata Pharmaceuticals | Stock | Health Care |
SPDR SP Target Price Odds Analysis
Coming from a normal probability distribution, the odds of SPDR SP jumping above the current price in 90 days from now is roughly 97.0%. The SPDR SP Pharmaceuticals probability density function shows the probability of SPDR SP etf to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the etf has a beta coefficient of 1.4274. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, SPDR SP will likely underperform. Additionally, sPDR SP Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of SPDR SP to move above the current price in 90 days from now is roughly 97.0 (This SPDR SP Pharmaceuticals probability density function shows the probability of SPDR Etf to fall within a particular range of prices over 90 days) .
SPDR SP Top Holders
| NAVFX | The Sector Rotation | Mutual Fund | Large Growth |
| PILL | Direxion Daily Pharmaceutical | Etf | Trading--Leveraged Equity |
| CAPTX | Canterbury Portfolio Thermostat | Mutual Fund | Tactical Allocation |
| LCAIX | Lazard Capital Allocator | Mutual Fund | Tactical Allocation |
| LCAOX | Lazard Capital Allocator | Mutual Fund | Tactical Allocation |
SPDR SP Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. SPDR SP market risk premium is the additional return an investor will receive from holding SPDR SP long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in SPDR SP. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although SPDR SP's alpha and beta are two of the key measurements used to evaluate SPDR SP's performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.05) |
SPDR SP Against Markets
Picking the right benchmark for SPDR SP etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in SPDR SP etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for SPDR SP is critical whether you are bullish or bearish towards SPDR SP Pharmaceuticals at a given time. Please also check how SPDR SP's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in SPDR SP without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
How to buy SPDR Etf?
Before investing in SPDR SP, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in SPDR SP. To buy SPDR SP etf, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of SPDR SP. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase SPDR SP etf. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located SPDR SP Pharmaceuticals etf in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased SPDR SP Pharmaceuticals etf, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the etf
It's important to note that investing in stocks, such as SPDR SP Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in etf prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy SPDR Etf please use our How to Invest in SPDR SP guide.
Already Invested in SPDR SP Pharmaceuticals?
The danger of trading SPDR SP Pharmaceuticals is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of SPDR SP is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than SPDR SP. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile SPDR SP Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether SPDR SP Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Pharmaceuticals Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Pharmaceuticals Etf: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Pharmaceuticals. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.